Roadmap for Advancing Pre-Clinical Science in Traumatic Brain Injury.
Roadmap for Advancing Pre-Clinical Science in Traumatic Brain Injury.
复制标题
DOI:
10.1089/neu.2021.0094
复制
发表时间:
2021-12
影响因子:
4.2
通讯作者:
Crawford F
中科院分区:
文献类型:
--
作者:
Smith DH;Kochanek PM;Rosi S;Meyer R;Ferland-Beckham C;Prager EM;Ahlers ST;Crawford F
Pre-clinical models of disease have long played important roles in the advancement of new treatments. However, in traumatic brain injury (TBI), despite the availability of numerous model systems, translation from bench to bedside remains elusive. Integrating clinical relevance into pre-clinical model development is a critical step toward advancing therapies for TBI patients across the spectrum of injury severity. Pre-clinical models include in vivo and ex vivo animal work—both small and large—and in vitro modeling. The wide range of pre-clinical models reflect substantial attempts to replicate multiple aspects of TBI sequelae in humans. Although these models reveal multiple putative mechanisms underlying TBI pathophysiology, failures to translate these findings into successful clinical trials call into question the clinical relevance and applicability of the models. Here, we address the promises and pitfalls of pre-clinical models with the goal of evolving frameworks that will advance translational TBI research across models, injury types, and the heterogenous etiology of pathology.
登录
查看更多内容
影响因子:
5.6
作者:
Chou A;Krukowski K;Morganti JM;Riparip LK;Rosi S
通讯作者:
Rosi S
DOI:
10.3233/jad-180726
发表时间:
2018
期刊:
Journal of Alzheimer's disease : JAD
影响因子:
--
作者:
Chen M;Song H;Cui J;Johnson CE;Hubler GK;DePalma RG;Gu Z;Xia W
通讯作者:
Xia W
影响因子:
3.7
作者:
Chou A;Morganti JM;Rosi S
通讯作者:
Rosi S
影响因子:
4.2
作者:
Bartnik-Olson, Brenda L.;Holshouser, Barbara;Ashwal, Stephen
通讯作者:
Ashwal, Stephen
影响因子:
4.2
作者:
Albalawi, Tamadher;Hamner, Jason W.;Tan, Can Ozan
通讯作者:
Tan, Can Ozan